Having the evolutionary distribution of casq1 and casq2 allowed us to assess the conservation of sites in Casq2 proteins where calsequestrin mutations in the human CASQ2, have been associated with CPVT (Fig. 2A,B)24,50,51. The gene discussed is CASQ2; the disease is catecholaminergic polymorphic ventricular tachycardia.